InsidersTradesSigma
Track the 엑세스바이오 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 엑세스바이오 has published 1 insider filings. Market capitalisation: €75.8bn. The latest transaction was filed on 12 March 2026 (Other). Among the most active insiders: 엑세스바이오. Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Access Bio is in the health and pharmaceutical sector, listed on the XKRX market. The company specializes in the development of innovative medical diagnostics.